🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has removed violative material and banned associated keywords and query recommendations. The organization stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, posts show dark colored parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.